OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

A. Sacher; M.R. Patel; W.H. Miller; Jayal Desai; E. Garralda; S. Bowyer; T.W. Kim; M. Miguel; A. Falcon; Matthew Krebs; J. Lee; M. Cheng; S.-W Han; Einat Shacham Shmueli; M. Forster; G. Jerusalem; E. Massarelli; L. Rodriguez; Hans Prenen; Patricia Lorusso

doi:10.1016/j.jtho.2022.07.023

OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

A. Sacher, M.R. Patel, W.H. Miller, Jayal Desai, E. Garralda, S. Bowyer, T.W. Kim, M. Miguel, A. Falcon, Matthew Krebs, J. Lee, M. Cheng, S.-W Han, Einat Shacham Shmueli, M. Forster, G. Jerusalem, E. Massarelli, L. Rodriguez, Hans Prenen, Patricia Lorusso

Division of Cancer Sciences (L5)

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	S8-S9
DOIs	https://doi.org/10.1016/j.jtho.2022.07.023
Publication status	Published - 1 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jtho.2022.07.023

Cite this

Sacher, A., Patel, M. R., Miller, W. H., Desai, J., Garralda, E., Bowyer, S., Kim, T. W., Miguel, M., Falcon, A., Krebs, M., Lee, J., Cheng, M., Han, S. .-W., Shacham Shmueli, E., Forster, M., Jerusalem, G., Massarelli, E., Rodriguez, L., Prenen, H., & Lorusso, P. (2022). OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation. S8-S9. https://doi.org/10.1016/j.jtho.2022.07.023

@conference{3c90cb2f24eb476ca396095347829bae,

title = "OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation",

author = "A. Sacher and M.R. Patel and W.H. Miller and Jayal Desai and E. Garralda and S. Bowyer and T.W. Kim and M. Miguel and A. Falcon and Matthew Krebs and J. Lee and M. Cheng and S.-W Han and {Shacham Shmueli}, Einat and M. Forster and G. Jerusalem and E. Massarelli and L. Rodriguez and Hans Prenen and Patricia Lorusso",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.jtho.2022.07.023",

language = "English",

pages = "S8--S9",

}

Sacher, A, Patel, MR, Miller, WH, Desai, J, Garralda, E, Bowyer, S, Kim, TW, Miguel, M, Falcon, A, Krebs, M, Lee, J, Cheng, M, Han, S-W, Shacham Shmueli, E, Forster, M, Jerusalem, G, Massarelli, E, Rodriguez, L, Prenen, H & Lorusso, P 2022, 'OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation', pp. S8-S9. https://doi.org/10.1016/j.jtho.2022.07.023

TY - CONF

T1 - OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

AU - Sacher, A.

AU - Patel, M.R.

AU - Miller, W.H.

AU - Desai, Jayal

AU - Garralda, E.

AU - Bowyer, S.

AU - Kim, T.W.

AU - Miguel, M.

AU - Falcon, A.

AU - Krebs, Matthew

AU - Lee, J.

AU - Cheng, M.

AU - Han, S.-W

AU - Shacham Shmueli, Einat

AU - Forster, M.

AU - Jerusalem, G.

AU - Massarelli, E.

AU - Rodriguez, L.

AU - Prenen, Hans

AU - Lorusso, Patricia

PY - 2022/9/1

Y1 - 2022/9/1

U2 - 10.1016/j.jtho.2022.07.023

DO - 10.1016/j.jtho.2022.07.023

M3 - Abstract

SP - S8-S9

ER -